Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.
about
Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetesConflicting effects of atazanavir therapy on atherosclerotic risk factors in stable HIV patients: A randomized trial of regimen switch to atazanavir.Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.The association between aortic distensibility and coronary flow reserve in newly diagnosed diabetic patients.The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus.
P2860
Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fenofibrate improves endotheli ...... en-label interventional study.
@en
Fenofibrate improves endotheli ...... en-label interventional study.
@nl
type
label
Fenofibrate improves endotheli ...... en-label interventional study.
@en
Fenofibrate improves endotheli ...... en-label interventional study.
@nl
prefLabel
Fenofibrate improves endotheli ...... en-label interventional study.
@en
Fenofibrate improves endotheli ...... en-label interventional study.
@nl
P2860
P356
P1476
Fenofibrate improves endotheli ...... en-label interventional study.
@en
P2093
Cristina Nita
Mihai Porojan
P2860
P2888
P356
10.1186/1758-5996-6-30
P577
2014-03-04T00:00:00Z
P5875
P6179
1049372513